4//SEC Filing
Watson David O. 4
Accession 0001127602-25-002389
CIK 0001492422other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 12:20 PM ET
Size
7.6 KB
Accession
0001127602-25-002389
Insider Transaction Report
Form 4
Watson David O.
General Counsel
Transactions
- Sale
Common Stock
2025-01-29$29.52/sh−695$20,519→ 144,299 total
Holdings
- 3,333(indirect: Indirect Owner (Custodial Account for Son))
Common Stock
- 70,136(indirect: By Trust)
Common Stock
- 6,667(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 28, 2025.
- [F2]This represents a custodial account held by the reporting person for the sole benefit of his minor son.
- [F3]The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
- [F4]The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001657719
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 12:20 PM ET
- Size
- 7.6 KB